- Biological Products Analysis Service Primary Structure Analysis Service Therapeutics Characterization Service | Advanced Structural Charge Heterogeneity Analysis Service Biopharmaceutical Impurities Analysis Service
- Preclinical Drug Development Active Ingredients Identification and Screening Service Drug Target Analysis Service Biopharmaceuticals Characterization Service Targeted Drug Delivery Service | Precise and Efficacious Customized Drug Development and Optimize Service
- Thematic Analysis Service High-Throughout Gene Knockout Services Biopharmaceutical Stability Analysis Service PROTAC Drug Off-Target Protein Assessment Service Biosimilar Assessment Service Generic Peptide Pharmaceuticals Assessment Service Research on Media Development and Optimization Vaccine Quality Research and Testing Solutions Antibody Drug Analysis Service mRNA Drug Analysis Service Medical Device Analysis Service
- Proteomics Analysis Service Sample Preparation Service Protein Analysis Service Quantitative Proteomics Service Post-Translational Modifications Proteomics Service Proteomics Service of Different Sample Types Targeted Proteomics Service Peptidomics Analysis Service Proteomics Bioinformatic Analysis Service High-Throughout Proteomics Analysis Service for Gene Knockout Chemical Proteomics Analysis Service
- Metabolomics Analysis Service Untargeted Metabolomics Service Targeted Metabolomics Analysis Service High-Throughput Metabolomics Service After Gene Knockout Metabolomics Bioinformatic Analysis Service More Services
- Lipidomics Analysis Service Untargeted Lipidomics Analysis Service Targeted Lipidomics Analysis Service Exosome Lipidomics Service Lipidomics MALDI Imaging Service Oxylipidomics Service
- Multi-Omics Analysis Service Integrative Lipidomics-Proteomics Analysis Service Integrative Transcriptomics-Metabolomics Analysis Service Integrative Transcriptomics-Proteomics Analysis Service Integrative Transcriptomics-Lipidomics Analysis Service Integrative Metabolomics-16S rDNA Sequencing Analysis Service Integrative Proteomics-Metabolomics Analysis Service Integrative PTM-Metabolomics Analysis Transcriptome Sequencing (RNA-sequencing) Service Metatranscriptomics Sequencing Service Full-Length 16S/18S/ITS Sequencing Service Prokaryotic Transcriptomics Sequencing Service Eukaryotic Non-Ginseng Transcriptome Sequencing Service Eukaryotic Transcriptome Sequencing Service 16S/18S/ITS Amplicon Sequencing Service Exosomal Sequencing Service
- Single Cell Analysis Service Single Cell Sequencing Service Single Cell Mass Cytometry Analysis
- Bioinformatics
Mechanism of C-Terminal Sequencing
Published: August 11, 2024
C-terminal sequencing is a critical analytical technique in protein chemistry, used to identify the amino acid sequence at the carboxyl terminus of a polypeptide chain.
Methods of C-Terminal Sequencing
1. Enzymatic Methods
Enzymatic methods involve the use of specific enzymes, such as carboxypeptidases, to cleave the protein at known sites near the C-terminus. These enzymes sequentially remove amino acids from the C-terminal end, facilitating the identification of residues one by one.
2. Chemical Methods
Chemical methods use reagents that react specifically with the terminal amino acid. For instance, hydrazine can react with peptide bonds to produce hydrazides, which can then be analyzed. Additionally, thiohydantoins can be derivatized and identified through chromatographic techniques, offering another approach to C-terminal sequencing.
Applications of C-Terminal Sequencing
1. Protein Characterization
Determining the C-terminal sequence is essential for protein characterization, aiding in the elucidation of the complete protein structure, including any post-translational modifications at the C-terminus.
2. Biotechnology and Drug Development
In biotechnology, C-terminal sequencing verifies the expression and processing of recombinant proteins. In drug development, it helps identify therapeutic peptides and assess their stability and activity.
Challenges and Limitations
1. Technical Challenges
A significant technical challenge in C-terminal sequencing is selectively and efficiently cleaving the terminal amino acid without affecting the internal sequence, requiring highly specific enzymes or reagents.
2. Sequence Complexity
Proteins with complex secondary or tertiary structures can hinder the accessibility of the C-terminus, complicating sequencing efforts. Additionally, post-translational modifications such as amidation or glycosylation at the C-terminus can further complicate the analysis.
The ongoing development of advanced techniques and reagents continues to enhance the accuracy and efficiency of C-terminal sequencing. However, achieving complete and unambiguous identification of the C-terminal sequence remains a challenging task in protein chemistry.
Advances in C-Terminal Sequencing Techniques
1. Mass Spectrometry-Based Approaches
Recent advancements have seen the integration of mass spectrometry (MS) for C-terminal sequencing. MS-based techniques provide high sensitivity and accuracy, allowing for the detailed analysis of the C-terminal amino acid sequence. Tandem mass spectrometry (MS/MS) further enhances this capability by enabling the fragmentation and subsequent identification of specific peptide sequences.
2. Next-Generation Sequencing (NGS) Technologies
Next-generation sequencing technologies have also been adapted for protein sequencing, including the C-terminus. These high-throughput methods can process multiple samples simultaneously, significantly increasing the speed and throughput of sequencing efforts. The application of NGS to protein sequencing is still in its infancy but holds great promise for future developments.
Future Perspectives
1. Improving Specificity and Efficiency
The future of C-terminal sequencing lies in improving the specificity and efficiency of the enzymes and reagents used. Research is ongoing to develop new carboxypeptidases and chemical agents that can more accurately and selectively target the C-terminal amino acid without interference from the rest of the protein.
2. Integrative Approaches
Combining different sequencing techniques, such as MS and NGS, may offer a more comprehensive understanding of protein termini. Integrative approaches can leverage the strengths of each method, potentially overcoming individual limitations and providing a more robust and complete sequencing solution.
As these advancements continue, the ability to accurately sequence protein C-termini will become increasingly reliable, opening new avenues for research and application in various fields of science and medicine. The integration of novel techniques and continuous improvement in existing methods will likely drive significant progress in the field of C-terminal sequencing.
Various methods, including enzymatic and chemical approaches, have been developed to accurately identify the C-terminal amino acid sequence. Despite the challenges and limitations, ongoing advancements in mass spectrometry and next-generation sequencing technologies hold promise for improving the accuracy and efficiency of C-terminal sequencing. MtoZ Biolabs provides integrate C-Terminal sequencing service.
How to order?
